|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/438 | |
| A61K 9/70 | |||
| A61K 9/48 | |||
| A61K 9/20 | |||
| A61K 9/02 | |||
| A61K 9/00 | |||
| A61P 31/04 | |||
| A61P 15/02 | |||
| A61K 47/54 | |||
| A61K 9/06 | |||
| A61K 47/10 | |||
| A61K 47/32 |
| (11) | Patento numeris | 3574900 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18760546.4 |
| Europos patento paraiškos padavimo data | 2018-02-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-12-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-04-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2018/076969 |
| Data | 2018-02-22 |
| (87) | Numeris | WO 2018/157750 |
| Data | 2018-09-07 |
| (30) | Numeris | Data | Šalis |
| 201710109978 | 2017-02-28 | CN |
| (72) |
MA, Zhenkun, CN
YUAN, Ying, CN
LIU, Yu, CN
WANG, Xiaomei, CN
|
| (73) |
Tennor Therapeutics Limited,
Room 711, Building B2 BioBay Science Park No. 218 Xinghu Street Suzhou Industrial Park, Suzhou, Jiangsu 215123,
CN
|
| (54) | NEW APPLICATIONS OF RIFAMYCIN-NITROIMIDAZOLE COUPLING MOLECULES |
| NEW APPLICATIONS OF RIFAMYCIN-NITROIMIDAZOLE COUPLING MOLECULES |